Pharmacological Applications of Icariin and Its Derivatives

Icariin, a prenylflavonoid glycoside isolated from plants of the Epimedium genus, and its bioactive derivatives such as icaritin and icariside II have attracted extensive attention for their versatile pharmacological properties. These compounds exhibit broad-spectrum anti-inflammatory, antioxidant and immunomodulatory activities, alongside notable roles in bone metabolism, cardiovascular protection and neuroprotection. In oncology, icariin and its derivatives have been shown to interfere with multiple hallmarks of cancer, including the induction of apoptosis, cell-cycle arrest, inhibition of angiogenesis and suppression of metastatic potential. Their ability to modulate key signalling pathways—such as JAK/STAT, MAPK/ERK and PI3K/AKT/mTOR—underpins a diverse range of antitumour effects across haematological and solid tumour models. Beyond oncology, icariin enhances osteoblastic differentiation and suppresses osteoclastogenesis, offering therapeutic promise in osteoporosis, while its vasoprotective actions counteract endothelial dysfunction, smooth muscle proliferation and foam-cell formation in atherosclerosis models. Metabolic benefits have also emerged, with deglycosylated metabolites demonstrating inhibitory activity against enzymes relevant to type 2 diabetes. Collectively, these findings support ongoing efforts to translate icariin derivatives into clinical candidates for multifaceted chronic diseases.

Research from Nature Portfolio

Recent studies have demonstrated that icariin exerts potent antitumour effects in oesophageal squamous cell carcinoma by triggering endoplasmic reticulum stress–mediated apoptosis. Treatment of carcinoma cell lines with micromolar concentrations of icariin resulted in elevated reactive oxygen species levels, upregulation of ER stress markers (including phosphorylated PERK, GRP78, ATF4 and CHOP) and increased caspase-mediated cell death. Manipulation of ER stress signalling by genetic silencing or pharmacological agents confirmed that activation of this pathway underlies the anticancer activity. These findings illuminate endoplasmic reticulum stress as a viable mechanism of action for icariin in solid tumours and suggest potential synergy with agents that target protein homeostasis.

Pharmacological Applications of Icariin and Its Derivatives publication trend

The graph below shows the total number of articles in pharmacological applications of icariin and its derivatives across all publications each year (not limited to Nature Index journals).

Technical terms

Prenylflavonoid: A flavonoid compound bearing a prenyl group, enhancing its lipophilicity and membrane interaction.

Autophagy: A cellular degradation process in which cytoplasmic components are sequestered within autophagosomes and delivered to lysosomes for recycling.

Endoplasmic reticulum stress: A cellular condition arising from accumulation of misfolded proteins within the ER, triggering adaptive or apoptotic responses.

AMPK: Adenosine monophosphate-activated protein kinase, a central energy sensor that regulates metabolic homeostasis and autophagy.

Xenograft model: An in vivo experimental system in which human cells or tissues are implanted in immunocompromised animals to study disease or therapeutic interventions.

References

1. Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer. Cancer Cell International (2024).
2. Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives. Frontiers in Pharmacology (2016).
3. Icariin displays anticancer activity against human esophageal cancer cells via regulating endoplasmic reticulum stress-mediated apoptotic signaling. Scientific Reports (2016).
4. Icariin, an Anti-atherosclerotic Drug from Chinese Medicinal Herb Horny Goat Weed. Frontiers in Pharmacology (2017).
5. Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents. Molecules (2017).